New Roche data for Evrysdi show improved motor function in pre-symptomatic babies after one year and confirm safety profile in previously treated people with spinal muscular atrophy (SMA)
Data from JEWELFISH, the first trial in a diverse population aged 1 to 60 years…
Vitalist Inc. Partners with Pattern to Accelerate Global E-Commerce Growth for Reebok Smartwatches